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Abstract: 
Gene expression is highly regulated at the step of transcription initiation, and 
transcription activators play a critical role in this process. RbpA, an 
actinobacterial transcription activator that is essential in Mycobacterium 
tuberculosis (Mtb), binds selectively to Group 1 and certain Group 2 σ factors. To 
delineate the molecular mechanism of RbpA, we show that the Mtb RbpA Sigma 
Interacting Domain (SID) and basic linker (BL) are sufficient for transcription 
activation. We also present the crystal structure of the Mtb RbpA-SID in complex 
with domain 2 of the housekeeping σ factor, σA. The structure explains the basis 
of σ selectivity by RbpA, showing that RbpA interacts with conserved regions of σA 
as well as the non-conserved region (NCR), which is present only in housekeeping 
σ factors.  Thus, the structure is the first to show a protein interacting with the 
NCR of a σ factor. We confirm the basis of selectivity and the observed 
interactions using mutagenesis and functional studies. In addition, the structure 
allows for a model of the RbpA-SID in the context of a transcription initiation 
complex. Unexpectedly, the structural modeling suggests that RbpA contacts the 
promoter DNA, and we present in vivo and in vitro studies supporting this finding. 
Our combined data lead to a better understanding of the mechanism of RbpA 
function as a transcription activator. 
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Significance  
 
Initiation of transcription in bacteria relies on a multisubunit RNA polymerase in 
concert with a dissociable σ subunit that confers promoter recognition and opening to 
reveal the DNA template strand. RbpA, a transcription activator unique to 
Actinobacteria and essential in Mycobacterium tuberculosis, associates tightly with 
sigma and is required for efficient initiation, although its mechanism of action is 
unclear. Here we solve the crystal structure of an M. tuberculosis σ/RbpA complex and 
present evidence indicating that RbpA activates transcription through novel contacts 
with promoter DNA. The work sheds light on the mechanism of transcription initiation 
by M. tuberculosis RNA polymerase, which is a proven antibiotic target. 
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\body 
Introduction 
Bacterial RNA polymerase (RNAP) comprises a catalytic core (subunit composition 
α2ββ’ω) that is active for transcription elongation but requires an additional dissociable 
subunit, the σ factor, for promoter-specific initiation (1, 2). All bacteria contain a single 
primary σ that is essential for viability and directs transcription of most genes during 
vegetative growth. Most bacteria also harbor alternative σ factors that can reprogram 
the RNAP to orchestrate adaptive responses to specific signals such as stress and 
morphological development (3). Primary σs can make up to four sequence specific 
contacts with promoter DNA via three conserved helical domains (σ2, σ3 and σ4) that are 
spread over one face of the RNAP (4-8). Within each structural domain are defined 
regions of sequence similarity; i.e., the structural domain σ2 comprises regions 1.2,  2.1, 
2.2, 2.3 and 2.4 (9). The key interactions involve the σ2 and σ4 domains, which are 
spaced appropriately to contact the -10 and -35 promoter elements, respectively (6).  
The vast majority of biochemical and genetic studies on bacterial transcription 
initiation have focused on Escherichia coli (Eco) RNAP and its primary σ, σ70.  Recently, 
it has emerged that the regulation of transcription initiation in the Actinobacteria 
phylum, which includes major pathogens, such as Mycobacterium tuberculosis (Mtb), 
and antibiotic producers, such as Streptomyces spp., is distinct from the Eco system by 
the dependence on two initiation factors, CarD and RbpA, neither of which is found in 
Eco (10-12). 
 In mycobacteria, the essential protein CarD has been shown to be present at 
most promoters in vivo and to function as a transcription activator in vitro (10, 13).  
More recently, Mtb CarD has been shown to activate transcription initiation by 
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stabilizing the RNAP open complex with promoters (RPo) by preventing collapse of the 
transcription bubble (14). CarD makes a direct protein/protein interaction with the 
RNAP β subunit β1-lobe, and structural models suggest it also contacts the upstream 
edge of the -10 promoter element DNA in RPo (13).   
RbpA was originally discovered in S. coelicolor (Sco) where it is a major 
component of RNAP holoenzyme (11). RbpA is found in all Actinobacteria, and like 
CarD, is essential for growth in Mtb (11, 12). In comparison to CarD, much less is known 
about the RbpA structural mechanism. 
The structural architecture of isolated RbpA has been defined by solution NMR 
(15, 16). A central core domain (RCD) comprises a β-barrel fold and is flanked by an 
unstructured 26 amino acid N-terminal tail and a C-terminal segment predicted to 
harbor two α-helices linked to the RCD by a 15 amino acid basic linker (BL; Fig. 1A). In 
the absence of core RNAP, RbpA can form a stable binary complex with the σ2 domain of 
the primary σ factors of both Sco (σHrdB) and Mtb (σA) (15, 16). The RbpA/σ2 interaction 
is mediated by the C-terminal segment (which we designate here the Sigma Interaction 
Domain, SID), and point mutations that disrupt σ binding also disrupt RbpA function 
(15). In addition to primary σ factors, RbpA interacts with certain Group 2 σ factors, σB 
in Mtb and σHrdA in Sco, but does not interact with Group 3 or Group 4 σ factors (15-17).  
RbpA is present at transcription initiation complexes in vivo and stimulates 
transcription in vitro from a wide range of Sco σHrdB-, Sco σHrdA-, Mtb σA-, and Mtb σB-
dependent promoters (15, 18), but the mechanism for RbpA-mediated transcription 
activation is unknown.  
Here, we show that the RbpA-BL and SID are sufficient for in vitro transcription 
activation by RbpA, and we determine the X-ray crystal structure of the Mtb RbpA/σA2 
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complex, revealing the essential RbpA-SID/σA2 interactions, as well as representing the 
first structure of a protein interacting with the non-conserved insert found exclusively 
in housekeeping σ factors. From this result, we use a combination of structural 
modeling, mutagenesis, and in vitro and in vivo functional studies to probe the 
mechanistic basis of RbpA function. Our results suggest that in addition to the RbpA-
SID/σA2 protein/protein interaction, RbpA/promoter DNA interactions are crucial in the 
role of RbpA as a transcription activator. 
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Results   
The RbpA-BL and SID are sufficient for transcription activation  
While the essential role of the RbpA-SID in RbpA function is clear, the roles of the other 
RbpA structural elements (N-terminal tail, RCD, BL) are not. We therefore tested 
truncated derivatives of Mtb RbpA, N-terminally fused to SUMO to improve stability, for 
transcription activation function using a mycobacterial transcription system and an Mtb 
vapB10 (Rv1398c) promoter template. The vapB10p promoter (19) is used here 
because it exhibits strong dependence on RbpA in vitro. As expected, an Mtb RbpA 
deletion mutant (containing only residues 1–71) lacking the BL and SID was unable to 
activate transcription in vitro (Fig. 1B, lanes 8-9). By contrast, the RbpA-SID and much 
of the BL (residues 72–C-terminus) showed partial in vitro function compared to full-
length RbpA with an equivalent N-terminal SUMO fusion (Fig. 1B, lanes 10-11.). We 
conclude that the RbpA-BL and SID are necessary and sufficient for at least partial RbpA 
in vitro transcription activation, but that other elements of RbpA (N-terminal tail and/or 
RCD) are required for full activity.  
 
X-ray crystal structure of the Mtb RbpA/σA2 complex 
To provide insight into RbpA function as a transcription activator, we determined the 
crystal structure of the Mtb RbpA/σA2 complex to 2.2 Å resolution (Figs. 1C, S1A, Table 
S2). Although crystallization trials were set up with a purified complex of a His6-SUMO-
σA2 fusion (containing σA2 residues 224-364) and full-length RbpA (1-111), MALDI-TOF 
analysis of the crystal contents revealed that both proteins were N-terminally 
proteolytically degraded, resulting in crystals containing multiple σA2 fragments 
(lacking up to 18 N-terminal residues; see supplemental methods) and multiple RbpA  
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fragments  (all including the BL and SID; see supplemental figures) (Fig. 1A). Electron 
density maps revealed the RbpA-SID (77-108) bound to σA2 (242-363) (Fig. 1C). 
Although the MALDI-TOF analysis indicated that the mixture of RbpA fragments 
crystallized included intact RbpA molecules, additional electron density was absent, and 
the rest of RbpA was presumed disordered or absent. 
The structure shows that the RbpA-SID comprises two α-helices (α1, α2; Fig. 1C), 
confirming previous sequence-based structural predictions (15-17). Four residues of 
the 15-residue RbpA-BL connecting the RbpA-SID to the RCD are also visible in the 
structure. Both α-helices of the RbpA-SID contact σA2, forming an intermolecular 
interface with a buried surface area of 948 Å2. 
 The RbpA-SID makes extensive contacts with residues from conserved regions of 
σA2 (1.2 and 2.3) as well as the NCR (Figs. 1C, 2A-C, S1).  Interacting with the primary σ-
NCR is a property RbpA shares with the unrelated Chlamydia trachomatis (Ctr) 
transcription factor GrgA, which binds to the Ctr σ66-NCR (20). Moreover, although 
structurally distinct from RbpA, the holoenzyme assembly factor Crl from enteric 
bacteria interacts with the equivalent region of the Group 2 sigma factor σS (21, 22). The 
co-crystal structure of RbpA/σA2 represents the first structure of an activator (or any 
protein) interacting with the NCR of a housekeeping σ. 
Previous studies identified two conserved arginine residues (Sco RbpA R89 and 
R90, corresponding to Mtb R88 and R89; Fig. 2B) that are critical for σ binding (15). The 
structure shows that these two residues form extensive electrostatic interactions with 
σA (Fig. 2C), explaining the mutagenesis results. Mtb RbpA-R88, in α1 of the SID, forms a 
salt bridge with σA residue E254, while RbpA-R89, located in the linker between the two 
SID α-helices, makes salt bridges with both E254 and D336 of σA.  
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A cluster of conserved hydrophobic RbpA residues (L94, L97, and L98; Figs. 2B, 
C), located on RbpA-SID α2, make extensive van der Waals contacts with residues of σA 
(Figs. 2C, S1). To determine if the interactions observed in the crystal structure are of 
wider importance, we performed bacterial two-hybrid (BTH) assays with a Sco RbpA 
mutant in which the residues corresponding to Mtb RbpA L97 and L98 (Sco RbpA V98 
and L99; Fig. 2B) were changed to alanine. The results reveal that these branched 
hydrophobic residues are necessary for Sco RbpA/σHrdB binding (Fig. S2A,B). 
 
Identification of RbpA residues involved in σ selectivity 
In addition to binding primary σ factors, RbpA binds some Group 2 σ factors (Mtb σB 
and Sco σHrdA) but not others (Sco σHrdC and σHrdD), and does not interact with the more 
diverse Group 3 (e.g. Mtb σF) or Group 4 (e.g. Sco σR) σ factors (15, 17). The RbpA-
SID/σA2 structure provides a basis to understand the σ selectivity of RbpA. An alignment 
of σ2 amino acid sequences of Mtb σA and σB with Mtb σF and Sco σHrdC (Fig. 2A) revealed 
that out of 21 Mtb σA residues contacting RbpA, 16 were identical in Mtb σB while only 
four were identical in Mtb σF, explaining why RbpA is specific to Group 1 and 2 σ factors 
(17).  Although there was extensive conservation between Mtb σA and Sco σHrdC among 
most RbpA-interacting residues, there were several positions in Sco σHrdC that were 
substituted with physico-chemically dissimilar amino acids that might impede RbpA 
binding (e.g. σA E248/σHrdC R59, σA K251/σHrdC T62, σA Y258/σHrdC R69). We tested this 
idea by mutating Mtb σA residues E248 and K251 in σR1.2 and L257and Y258 in the 
NCR, changing each position to the equivalent residue in Sco σHrdC (Fig. 2A).  σA(RT) 
contained the mutations E248R and K251T,  σA(VR) contained L257V and Y258R 
mutations, and σA(RTVR) had all four positions altered to the equivalent positions in Sco 
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σHrdC. BTH assays suggested that all three mutants were defective in RbpA binding (Fig. 
2D). To support this, σA(VR) and σA(RTVR) mutants were overexpressed, purified, and 
tested by in vitro transcription on the vapB10p promoter template. In the absence of 
RbpA, σA(VR) and σA(RTVR)  directed basal transcription activity to the same extent as wild 
type σA. However, neither was responsive to RbpA, confirming that the interaction 
between σ and RbpA is crucial for the transcription activation role of RbpA (Fig. 2E). 
 
RbpA interacts directly with promoter DNA  
To gain insight into the role of RbpA in transcription initiation by RNAP holoenzyme, we 
generated a structural model of the complex between RbpA and RPo by superimposing 
the conserved regions of σA2 from the Mtb RbpA-SID/σA2 complex (Fig. 1C) onto the 
corresponding regions of Taq σA2 in an RPo model (6, 23) (0.681 Å root-mean-square 
deviation over 93 Cα atoms) (Fig. 3), resulting in an RbpA/RPo model with no steric 
clashes. In the model, the RbpA-SID/σA2 interaction positions the RbpA-BL (Fig. 1A) on 
the minor-groove side of the duplex promoter DNA just upstream of the -10 element, 
with absolutely conserved RbpA-R79 (Fig. 2B) positioned to interact with the non-
template strand (nt-strand) DNA phosphate backbone at the -14 position with respect 
to the transcription start site at +1 (Fig. 3B). In addition, absolutely conserved RbpA-
M84 (Fig. 2B) in α1 is positioned to play a role in DNA binding through van der Waals 
interactions (Fig. 3B). Also note that the next three residues N-terminal to the modeled 
portion of RbpA are all lysines (K73, K74, K76), which may also play a role in forming 
electrostatic interactions with the DNA phosphate backbone (Fig. 3B).  
 To test the hypothesis of an RbpA/DNA interaction, we used formaldehyde 
cross-linking, which links atoms 2 Å apart (24). In order to form stable RNAP/DNA 
 12 
complexes, we used a fork-junction template (6, 25) comprising the vapB10 promoter 
(VFJ-28; Figs. 4A, S3A) along with an anti-consensus control (VFJ-28anti; Fig. S3A). The 
inclusion of RbpA in cross-linking reactions led to the appearance of a new band (Fig. 
4A, lane 3), which was confirmed to be an RbpA-DNA crosslink since a slower migrating 
band appeared when the assay was repeated with SUMO-RbpA (Fig. 4A, lane 4). 
Furthermore, RbpA-DNA cross-linking was detected with SUMO-RbpA(72-111), which 
includes the RbpA-BL and SID, but not with SUMO-RbpA(1-71) lacking the RbpA-SID 
essential for σA binding and activity (Fig. 4A, lanes 5-6). This finding is consistent with 
the ability of SUMO-RbpA(72-111), but not SUMO-RbpA(1-71), to activate transcription 
(Fig. 1B). No crosslinking was detected with VFJ-28anti or with reactions that lacked 
core RNAP (Fig. S3B), indicating that RbpA/σA2 interactions with DNA occur only in the 
context of RNAP holoenzyme/promoter complexes.  
 An RbpA/promoter DNA interaction would be predicted to increase the overall 
affinity of RNAP for promoter DNA. To test this hypothesis, we measured RNAP binding 
to a Cy3-labeled duplex vapB10 promoter template (dsVapB; Fig. S4A) using a 
fluorescence anisotropy assay (26). We found that addition of RbpA decreased the 
dissociation constant, KD, for binding to the promoter DNA nearly two-fold (Fig. 4B), 
consistent with the modest activation activity of RbpA in abortive initiation (Fig. S4B) 
and run-off (Fig. 1B) transcription assays. On the other hand, the RbpA-R79A mutant 
had no significant effect on RNAP promoter binding (Fig. 4B), consistent with the 
hypothesis that RbpA-R79 plays an important role in DNA binding (Fig. 3B). Wild type 
RbpA had no significant effect on RNAP binding to Cy3-labeled single-stranded DNA 
comprising only the -10 and discriminator elements (Table S3), supporting the 
structure-based hypothesis that the effect of RbpA on RNAP-promoter binding is 
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through the interactions of RbpA with duplex DNA just upstream of the -10 element 
(Fig. 3).  
 
DNA interaction via RbpA-R79 is critical for transcription activation  
We hypothesized that an interaction between RbpA and DNA upstream of the -10 
element might underlie the transcription activation function of RbpA. To test this we 
used multi-round in vitro transcription assays and found that while Mtb RbpA-M84A 
retained partial activity, Mtb RbpA-R79A completely failed to stimulate transcription 
from a vapB10 promoter template (Fig 4C, lanes 5-6). In order to investigate the 
importance of these residues in vivo, we performed experiments in Sco where RbpA is 
required for normal growth but not essential for viability. The Sco mutants rbpA-R80A 
and rbpA-M85A (corresponding to Mtb RbpA R79A and M84A) were cloned into an 
integrative vector and used to transform the ∆rbpA Sco mutant S129 (15). The rbpA-
R80A and rbpA-M85A alleles retarded growth leading to smaller colonies on agar plates 
compared to the control rbpA-WT strain (Fig. S5).  These data indicate that the 
conserved Mtb/Sco RbpA R79/80 and M84/85 residues are critical for normal rbpA 
function in vivo.  
 
Discussion 
We propose that a key role of the RbpA-SID/σA2 interaction in transcription activation is 
to position the RbpA-BL near the upstream edge of the -10 promoter element to 
facilitate its interaction with the DNA phosphate backbone. Adding favorable 
protein/DNA contacts to the transcription initiation complex would potentially stabilize 
a transcription initiation intermediate, which is consistent with findings that RbpA 
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activates transcription primarily by stimulating RPo formation (15, 17). The role of 
RbpA-R79, which structural modeling predicts could contact the nt-strand DNA 
phosphate backbone at the -14 position (Fig. 3B), appears to be particularly significant. 
This residue is absolutely conserved among RbpA orthologues (Fig. 2B), stabilizes the 
binding of RNAP to promoter DNA (Fig. 4B), and is required for RbpA transcription 
activation in vitro (Fig. 4C) and for full RbpA function in vivo (Fig. S5). Strikingly, the 
RbpA-BL also contains three lysine residues (K73, K74, K76; Figs. 2B, 3B), which, 
although not modeled in the structure, might also contribute to interactions with the 
DNA phosphate backbone around the -14/-15 positions (Fig. 3B). 
Although the RbpA-BL and SID together are sufficient for partial transcription 
activation in vitro, full activation requires full-length RbpA (the N-terminal tail/RCD) 
(Fig. 1B). We suggest that the N-terminal tail and/or RCD likely form additional 
interactions with RNAP. Interactions between RbpA and core RNAP have been proposed 
previously, and putative interactions have been mapped to two widely spaced regions 
of RNAP (18, 27). However, our RbpA-SID/RPo structural model is completely 
incompatible with previous claims that RbpA interacts with RNAP either in the active-
site channel near the Rif binding site (27, 28) (Fig. S6A) or with a different region of the 
β-subunit (18) (Fig. S6B). Because of the location and orientation of the N-terminus of 
the RbpA-SID in our structural model, it would be impossible for any part of RbpA to 
span the distance from the N-terminus of our model to either of the putative sites (Fig. 
S6). The binding site near the Rif pocket was originally inferred based on functional 
data (28), then refined on the basis of a single crosslink (27). The other β-subunit 
determinant was identified using cleavage experiments through hydroxyl-radicals 
generated from Fe-BABE attached to the lone Cys-residue of the RbpA-RCD. In any case, 
whether or not the RbpA-RCD or N-terminal tail binds RNAP at all has not been 
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established, and if they do, our RbpA-SID/RPo model suggests that the likely RNAP 
binding determinant is on the β’ subunit on the top of the clamp domain (Fig. S6A). 
More experiments will be required to resolve these inconsistencies. A possible 
interaction with the RNAP clamp domain has also been proposed for Crl, a σS-RNAP 
holoenzyme assembly factor found in Eco and other γ-proteobacteria. Crl is thought to 
bind to a surface-exposed region of σS2 that is equivalent to the surface of σA2 bound by 
RbpA (21).  
 Both RbpA and CarD are essential transcription activators in Mtb (10, 12). CarD 
is associated with essentially all σA promoters in M. smegmatis in vivo (13), and results 
suggest that RbpA also likely functions at all σA promoters in vivo (11). Therefore, it 
seems likely that RbpA and CarD may function simultaneously on the same 
RNAP/promoter complexes. Indeed, structural modeling indicates that RbpA and CarD 
interactions with RPo are completely compatible, each interacting with DNA upstream 
of the -10 element but from opposite sides of the DNA. Future studies will address the 
influence of these two transcription regulators on each other and their possible role in 
modulating global transcription patterns in the Actinobacteria. 
 
 
 
 
 
 
Materials and Methods: 
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Full details of the methods used are presented in the SI Materials and Methods 
 
Strains, plasmids and growth conditions. Strains, plasmids and oligonucleotides are 
described in Table S1. Sco A3(2) strains were conjugated with Eco ET12567 (pUZ8002) 
and cultivated on mannitol-soya (MS) agar or in Yeast-Extract Malt-Extract (YEME) 
liquid medium  (29). Bacterial two hybrid analysis was carried out using Eco BTH101 
derivatives as described (15). 
 
Protein Expression and Purification. For crystallography, σ2 (codons 224-364) and 
RbpA (codons 1-111) from Mtb were cloned into a His6 pET SUMO co-expression vector, 
and proteins were over-expressed in Eco BL21(DE3) cells (Novagen). The complex was 
purified by Ni-affinity chromatography and size exclusion chromatography. For 
fluorescence anisotropy, Mtb RbpA and Mtb RbpA-R79A were cloned into a His6 pET28-
based vector, and were expressed and purified as described for the complex. Core 
RNAP, σA, and CarD were over-expressed and purified as described (14). For in vitro 
transcription and cross-linking assays, Mtb RbpA and SUMO-RbpA fusions and mutant 
derivatives were cloned into pET20b (Novagen) and pET SUMO (Life Technologies), 
respectively, overexpressed in Eco BL21(pLysS), and purified. The σA and mutant 
derivatives were cloned into pET15b and purified from Eco BL21(pLysS). 
 
X-ray Structure Determination of the RbpA/σA2 Complex. The purified complex was 
concentrated to ~15 mg/mL by centrifugal filtration, and crystals were grown at 22 °C 
by sitting drop vapor diffusion. MALDI-TOF MS was performed on the washed, 
dissolved crystals to determine the protein content using a Spiral TOF JMS-S3000 (JEOL, 
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Tokyo, Japan). The structure was solved using an Mtb σA2 homology model based on a 
structure of Taq σA2 with the non-homologous NCR removed [1KU2;(4)] (Table S2). 
 
Fluorescence Anisotropy. Fluorescence measurements were performed using an 
Infinite M1000pro plate reader (Tecan). Reactions were performed with Cy3-labeled 
duplex vapB10 DNA (Fig. S4A, Tri-link for labeled nt-strand, Oligos Etc. for unlabeled 
template strand) extending from -36 to +1, or single stranded Cy3 labeled DNA (Table 
S3, Tri-link) extending from -12 to +1. RNAP binding to duplex DNA gave poor signal-to-
noise data without the addition of CarD. Recent studies have shown that Mtb RNAP 
makes relatively unstable open complexes and displays short half lives on duplex 
promoter DNA without CarD (14). Therefore, these assays were performed in the 
presence of CarD. Data were analyzed using Prism software. 
  
Formaldehyde cross-linking. The crosslinking assay was modified from (24) and used 
as substrate vapB10 fork-junction DNA (VFJ-28) including an 18 bp double stranded 
region extending from -28 to -12 followed by a single-stranded extension from -11 to -3 
on the non-template strand (Fig. S3A). Cross-linking was performed for 2 min in the 
presence of 60 mM formaldehyde.  
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Figure Legends 
 
Fig. 1. Structural and functional analyses of RbpA-SID /σA2. (A) Schematic of RbpA and 
σA domains. Domain 2 of Mtb σA is shown in orange with the NCR in cranberry, and the 
remaining regions colored gray. The SID and basic linker of RbpA are colored purple, 
and the remaining regions colored gray.   Regions visible in the crystal structure are 
flanked by dashed lines. (B) Multiple round in vitro run-off transcription reactions using 
the vapB10 promoter template. Reactions contained core Mbo RNAP (50 nM), σA (250 
nM), and RbpA derivatives (500 nM, or 1.25 μM), as indicated. Lanes correspond to full 
length RbpA (residues 1-111, lanes 4 and 5), SUMO-RpbA full length (RbpA residues 1-
111 fused to SUMO, lanes 6 and 7), SUMO-RbpA-RCD (RbpA residues 1-71 fused to 
SUMO, lanes 8 and 9) and SUMO-RbpA-SID (RbpA residues 71-111 fused to SUMO, lanes 
10 and 11).  A graphical representation based on duplicate data sets (standard deviation 
indicated) is illustrated above, normalized to the data obtained with σA in the absence of 
RbpA. (C) Crystal structure of Mtb RbpA-SID in complex with σA2 is shown in ribbon and 
colored as in (A).  
 
Fig. 2. The X-ray crystal structure of the Mtb RbpA/σA2 complex explains the σ 
specificity of RbpA. (A) Amino acid sequence alignment of conserved regions 1.2 to 2.3 
in σ2 domains of Mtb σA, σB, and σF, and Sco σHrdC.  The following amino acids, written in 
single letter nomenclature, were considered homologous and grouped as indicated 
within parenthesis: (VLMA), (RK), (ED), (YFW), (TS) and (QN). Remaining residues (H, 
C, P and G) were not grouped. The σA residues that contact RbpA are indicated by red 
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dots, with those that are targeted for mutagenesis outlined in black. (B) Alignment of 
RbpA BL and SID from diverse representatives of the order Actinobacteria. Mtb, M. 
tuberculosis; Sco, S. coelicolor A3(2), Fsp, Frankia sp.; Krd, Kineococcus radiotolerans; 
Cac, Catenulispora acidiphila; Mau, Micromonospora aurantiaca; Jga, Jiangella 
gansuensis; Gar, Glycomyces arizonensis; Agr, Actinomyces graevenitzii.  Residues were 
considered in the same conservation group as (A). Green dots indicate residues that are 
suggested by the RbpA/RPo model to come in close contact with DNA; blue dots 
highlight conserved arginine residues demonstrated important for binding σ (Tabib-
Salazar et al., 2013); white dots indicate residues forming a hydrophobic interface 
between RbpA and σ and shown important for binding σ (this study). (C) Highlighted 
RbpA-SID residues required for σA  binding. RbpA residues R88 and R89 form a cluster 
of salt bridges with σA residues E254 and D336 (selected interactions indicated by 
dotted lines). RbpA L94, L97, and L98 make van der Waals interactions with σA residues 
Y258, A259, I284 and K251. (D) BTH analysis of Mtb RbpA interactions with Mtb σA 
mutants predicted to be defective in RbpA binding. Selected σA residues that contact 
RbpA were changed to equivalent residues in Sco σHrdC as described in the text. The 
coding sequences of rbpA were fused to the T18 subunit of Bordetella pertussis 
adenylate cyclase in pUT18, whereas the sigma factor genes were fused to the T25 
subunit in pKT25 (15).  β-galactosidase assays were performed in triplicate (standard 
deviations indicated), and results are presented as % Miller units relative to wild-type 
Mtb σA. (E) RbpA activation of the vapB10 promoter using σA mutants highlighted in (A). 
RbpA activation on mutant sigmas σA(VR) or σA(RTVR) was compared to wild-type σA(WT) 
using multiple round in vitro run-off transcription reactions. Reactions contained core 
Mbo RNAP (50 nM), wild-type σA(WT), σA(VR), or σA(RTVR) (each 250 nM) and the presence 
or absence of RbpA (500 nM), as indicated. A graphical representation based on 
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triplicate data sets, with standard deviation indicated, is illustrated above, normalized 
to the data obtained with σA(WT) in the absence of RbpA. 
 
Fig. 3. Structural model of Mtb RbpA-SID on an RPo complex. (A) A model of the RbpA-
SID/RPo complex was generated by superimposing conserved regions of Mtb σA2 (from 
the Mtb RbpASID/σA2 structure) with Taq σA in an RPo model. Protein and DNA elements 
are colored as indicated. RNAP is shown as a molecular surface; RbpA-SID/σA2 is shown 
in ribbon; and DNA is shown as a phosphate backbone worm. (B) A magnified view of 
the RbpA/RPo model shows that RbpA is positioned to make contacts with the DNA 
upstream of the -10 promoter element. RbpA amino acids R79, located in the RCD-SID 
linker, and M84, located in α1, are in position to contact the nt-strand phosphate 
backbone at the -13/-14 position. RbpA-M84 makes non-polar contacts with Mtb σA 
residue K334, which interacts with -12T at the beginning of the transcription bubble. 
RbpA sequence reveals three conserved, positively charged lysine residues K76, K74, 
K73 (represented by purple dots) located in the RCD-SID linker that would be well 
positioned to interact with the negatively charged DNA phosphate backbone.  
 
Fig. 4.  RbpA directly contacts the DNA and increases affinity of holenzyme to promoter 
DNA. (A) RbpA cross-links to fork junction promoter DNA. Reactions contained VFJ-28 
DNA 5’-labeled on the non-template strand, core Mbo RNAP (E) at 200 nM, σA (1 μM), 
and native or SUMO-fused derivatives of RbpA (2 μM), as indicated. Complexes were 
allowed to form at 37oC for 15 min before treatment with formaldehyde. Cross-linked 
species were separated by 4-12% SDS-PAGE and visualized by phosphorimaging. The 
vapB10 promoter-based fork junction DNA template VFJ-28 is illustrated, indicating the 
-10 element (blue) and labeled non-template strand (asterisk). (B) RbpA increases 
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RNAP affinity for promoter DNA. Representative fluorescence anisotropy binding 
curves show RNAP binding to Cy3-labeled vapB10 promoter DNA (Fig. S4A). Standard 
error bars and average KDs are based on triplicate trials. Inset shows average fold 
activation (normalized to no RbpA). WT RbpA increases affinity of RNAP for promoter 
DNA while RbpA-R79A has little-to-no effect on binding. Error bars are based on 
average fold change from nine experiments. (C) RbpA residues R79 and M85, predicted 
to bind DNA, are important for in vitro transcription activation. Multiple round in vitro 
run-off transcription reactions containing Mbo RNAP (50 nM), σA (250 nM), and RbpA 
(500 nM, or 1.25 μM) using the vapB10 promoter as template.  A graphical 
representation based on triplicate data sets, with standard deviation indicated, is 
illustrated above, normalized to the data obtained with σA in the absence of RbpA.  
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SI Materials and Methods: 
Protein Expression and Purification. For crystallography, σA2 (codons 224-364) and rbpA 
(codons 1-111) from Mtb were chemically synthesized as a single DNA fragment with Eco 
codon usage and independent T7 promoter and translation initiation signals for rbpA 
(Genscript), cloned as a BamHI-HindIII fragment into a His6 pET SUMO expression vector, 
and transformed into Eco BL21(DE3) cells (Novagen). Transformed cells were grown at 37 
°C in the presence of 50 μg/ml kanamycin to an OD600 of 0.6, at which point the 
temperature was lowered to 30 °C, and protein expression was induced with 500 µM IPTG 
for 3 h. Cells were harvested by centrifugation and resuspended in Lysis Buffer [20 mM 
Tris-HCl, pH 8.0, 0.5 M NaCl, 5 mM imidazole, 5% glycerol (v/v), 0.5 mM β-
mercaptoethanol] supplemented with 1 mM PMSF and protease inhibitor cocktail. Cells 
were lysed by French press (Avestin), and lysate was cleared by centrifugation. Clarified 
lysate was loaded on a Hi-Trap IMAC Ni2+-chelating column (GE Healthcare) and eluted 
with Lysis Buffer containing 250 mM imidazole. The elution was directly loaded on a size 
exclusion column (SuperDex-200 16/16, GE healthcare) equilibrated with 20 mM Tris-HCl, 
pH 8, 0.5 M NaCl, 5% glycerol (v/v), 1 mM DTT, 1 mM EDTA. The sample was concentrated 
to 15 mg/ml by centrifugal filtration and stored at -80 °C. For fluorescence anisotropy, 
Mtb RbpA and Mtb RbpA-R79A were cloned into a His6 pET28-based vector, and the 
plasmid was transformed into Eco Rosetta 2 BL21(DE3) cells. The proteins were 
overexpressed and purified using the same buffers and techniques as the RbpA/σ2 co-
expressed complex. Core RNAP, σA, and CarD were over-expressed and purified using 
previously described method (14).  
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For in vitro transcription and cross-linking assays, pSX500, which contains Mtb rbpA 
cloned in pET20b, as well as mutant derivatives, were overexpressed in Eco BL21(DE3) 
pLysS following a 15 min cold-shock of cultures (OD600 0.4-0.7) on ice, which improved 
protein solubility, and induction with 1 mM IPTG for 3h. Protein was purified by ion 
exchange chromatography (HiTrap Q SepharoseTM Fast Flow and Mono Q 5/50 GL, GE 
Healthcare) and size exclusion chromatography (HiLoad 16/60 Superdex 200, 
GE Healthcare).  To generate N-terminal SUMO fusions of Mtb RbpA (amino acid residues 1-
111) and truncated derivatives (amino acid residue 1-71 and 72-111), RbpA derivatives 
were cloned into pET SUMO (Invitrogen) as BamHI–HindIII fragments, overexpressed in 
Eco BL21(pLysS) as described above, and purified by a sequential Ni-affinity 
chromatography (Ni2+-charged iminodiacetic acid sepharose; Sigma-Aldrich), ion exchange 
chromatography (Mono Q 5/50 GL, GE Healthcare) and size exclusion chromatography 
(HiLoad 16/60 Superdex 200, GE Healthcare). σA and mutant derivatives (σA(VR) and 
σA(RTVR)) were cloned into pET15b and purified from Eco BL21(pLysS) following induction 
with 1 mM IPTG for 3 h at 30°C. Cell pellets were resuspended in ice-cold Lysis Buffer and 
following cell lysis by sonication, clearing of cell lysates by centrifugation and binding to a 
Ni column (see above), protein was eluted by thrombin-cleavage (Sigma-Aldrich), then 
further purified by size-exclusion chromatography as outlined above.  
 
Crystallization of RbpA/σA2 Complex. Crystals of the RbpA/σA2 complex were grown at 
22 °C via sitting drop vapor diffusion against a reservoir solution of 0.1 M Tris, pH 8.5, and 
0.5 M ammonium sulfate, at a protein concentration of 15 mg/ml. Drops were set up with a 
1:1 ratio of His6-SUMO-σA2-RbpA:crystallant. Crystals measuring approximately 50 μm took 
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3 days to grow and were cryoprotected in reservoir solution plus 30% (v/v) ethylene 
glycol.  
 
MALDI-TOF-MS of Crystals. One to two crystals were removed from the mother liquor 
and briefly washed in cold water and subsequently dissolved in matrix solution, which 
consisted of a saturated solution of α-cyano-4-hydroxycinnamic acid (CHCA) in a 
1:3:2 (v/v/v) mixture of formic acid/water/isopropanol (FWI). An aliquot of 0.5 μl of the 
protein-matrix solution was transferred onto a MALDI plate pre-coated with an ultrathin 
layer. The ultrathin layer was prepared and laid on the plate as previously published (30, 
31). The sample spots were washed for a few seconds with 2 μl of cold 0.1% aqueous 
trifluoroacetic acid (TFA) solution. MALDI spectra were acquired in linear, delayed 
extraction mode using a Spiral TOF JMS-S3000 (JEOL, Tokyo, Japan) equipped with a 
Nd:YLF laser, delivering 10-Hz pulses at 349 nm. Delayed extraction time was set at 1 ms, 
and acquisition was performed with a sampling rate of 2 ns. Each MALDI spectrum 
corresponded to an average of 500 scans. Mass calibration was performed using a 
technique of pseudo-internal calibration wherein a few shots on a nearby calibrant spot 
were collected and averaged with the sample shots into a single spectrum. The spectra 
were processed and analyzed using MoverZ (Proteometrics, LLC). MALDI-TOF analysis of 
the crystals revealed that both σA2 and RbpA were proteolytically degraded at their N-
termini. The crystals were composed of mixtures of σA missing up to 18 N-terminal 
residues, and two sets of RbpA fragments. Fragments of σA detected included: S224-R364, 
A230-Q362, Y231-A363, L233-R364, L240-Q362, N242-R364. Two groups of N-terminal 
variants of RbpA were detected: One group contained most of the N-terminal region, 
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including all of the RCD (beginning at M1, R10, S15, E17, R20). The second group lacked the 
RCD and included N-terminal variants starting at R57, G59, L64, G67, K74). All RbpA 
variants contained the native C-terminal residue G111. 
 
Data Collection and Refinement of σA2-RbpA Complex. X-ray diffraction data were 
collected at the Brookhaven National Synchroton Light Source X29 beamline and integrated 
and scaled using HKL2000 (32). Electron density maps were generated using molecular 
replacement with an Mtb σA2 homology model (ExPASy SWISS MODEL) based on a 
previously solved structure of the corresponding domain from Taq σA [1KU2; (4)]. The 
model was built using reiterative cycles of manual building with COOT (33) and refinement 
with Phenix (34) (Table S2). The final model included residues 242-363 of σA and 77-108 of 
RbpA. The RCD of RbpA, which lacked density, was presumed disordered. The PDBePISA 
server (http://www.ebi.ac.uk/pdbe/pisa/) was used to calculate intermolecular buried surface 
areas (35).  
 
Fluorescence Anisotropy. Fluorescence measurements were performed using an Infinite 
M1000pro plate reader (Tecan) in a 384 well plate with a final reaction volume of 25 uL. 
Holoenzyme was formed at 37°C using a 1:1.5 ratio of core RNAP:σA. All proteins were 
dialyzed and then serially diluted in Anisotropy Buffer consisting of 100 mM potassium-
glutamate, 10 mM HEPES, pH 8, 10 mM MgCl2, 0.1 mM DTT, 0.02% TWEEN 20, and 5% 
(v/v) glycerol. When used, RbpA was added to RNAP in 5-fold excess. Protein complexes 
were serially diluted in Anisotropy Buffer to obtain RNAP concentrations ranging from 5 
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nM to 3 μM. For assays with Cy3-labled single stranded DNA extending from the -12 to +1 
(Tri-link, Table S3), DNA was diluted in Anisotropy Buffer and added to the protein mixture 
at a final concentration 200 nM. For assays performed with double stranded vapB10 DNA 
extending from the -36 to +10, Cy3-labeled non-template strand DNA (Tri-link) was 
annealed to unlabeled template strand DNA (Oligos Etc.), diluted in Anisotropy Buffer, and 
added to the protein mixture at a final concentration of 10 nM. Measurements of RNAP 
binding to double-stranded DNA was noisy without the addition of CarD [a result of the 
unstable open complex and short half-life of M. bovis RNAP; (14)], so these assays included 
CarD (in 3-fold excess over RNAP). Data were analyzed using Prism software. Assays with 
single-stranded DNA were performed in triplicate. For assays with duplex DNA, three 
experiments composed of side-by-side triplicate trials for each condition were performed. 
 
Formaldehyde cross-linking. Fork-junction DNA was prepared by labeling the 5’ end of 
the non-template oligonucleotide using [γ32P]ATP, annealing with 3-fold molar excess of 
template strand oligonucleotide, followed by purification using a NAP-5 column 
(GE Healthcare). The fork-junction template VFJ-28 contained an 18 bp double stranded 
region from -28 to -12 followed by a single-stranded extension from -11 to -3 on the non-
template strand (Fig. S3A). In control experiments, an anti-consensus -10 sequence was 
used (VFJ-28anti), changing the -10 element from TATGAT to AGTGAC. σA was mixed with 
Mtb RbpA and mutant and truncated derivatives on ice for 10 min before the addition of 
core M. bovis (Mbo) RNAP. Reactions were then set up containing 400 nM σA, 200 nM core 
RNAP, various concentrations of RbpA, ~10 nM fork junction DNA in binding buffer [40 
mM Tris-HCl, pH 7.9, 10 mM MgCl2, 0.6 mM EDTA, 20% (v/v) glycerol, 0.8 mM potassium 
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phosphate (pH 7.5), 0.75 mM DTT, and 0.125 mg/ml BSA] and equilibrated at 37C for 15 
min. Cross-linking was initiated by the addition of formaldehyde (60 mM final) and stopped 
by the addition of 2x stop buffer (4% SDS, 20% glycerol, 10% β-mercaptoethanol, 0.004% 
bromophenol blue, 125 mM Tris-HCl, pH 6.8) after 2 min. Samples were loaded on Precast 
NuPAGE® 4-12% Bis-Tris gels (Invitrogen) at 100V for 3 h at 10C, dried, then analyzed 
by phosphorimagery.  
 
In vitro transcription. Multi-round run-off and abortive initiation in vitro transcription 
assays were carried out using core Mbo RNAP, purified Mtb σA and Mtb RbpA or mutant and 
truncated derivatives essentially as described (15). The vapB10 promoter template was 
amplified by PCR using the oligonucleotides vapB10_F (5’-GCGCTGAAGAGGGCGTTGCAC) 
and vapB10_R (5’-TTCAGCAGGAGGCGGATCAG). Multi-round assays, giving rise to a 109 nt 
run-off transcription product, were performed at 37oC and contained 5 nM template in 
reaction buffer [40 mM Tris-HCl, pH 7.9, 10 mM MgCl2, 0.6 mM EDTA, 20% (v/v) glycerol, 
0.8 mM potassium phosphate (pH 7.5), 0.75 mM dithiothreitol, and 0.125 mg/ml BSA]. 
Reactions were pre-incubated at 37ᴼC for 10 min before the addition of NTP mix [200 M 
ATP, GTP, CTP, 50 μM UTP, including 5 μCi [α-32P] UTP (>800 Ci/mmol), GE Healthcare], 
and incubated for 10 min. Reactions were halted by addition of an equal volume of in vitro 
loading dye [80% (w/v) formamide, 0.01 % (w/v) xylene cyanol, 0.01 % (w/v) 
bromophenol blue], separated on denaturing 8% polyacrylamide gels, and quantified by 
phosphorimaging. Abortive initiation assays were performed at 37 °C in a buffer containing 
10 mM Tris-HCl, pH 8.0, 100 mM potassium-glutamate, 10 mM MgCl2, 0.1 mM EDTA, 0.1 
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mM DTT, and 50 μg/mL BSA. Core RNAP (50 nM), σA (250 nM) and RbpA (500 nM, when 
used) were preincubated at 37°C for 5 min. DNA (10 nM) was added and the reaction was 
incubated for 15 min to allow RPo to form. Abortive transcription was initiated with an ApU 
dinucleotide primer (250 μM), [α-32P]GTP (1.25 μCi), and unlabeled GTP (50 μM). After 10 
min, reactions were quenched with 2x stop buffer (8M urea, 0.5x TBE, 0.05% bromophenol 
blue, 0.05% xylene cyanol) and separated on a 23% urea-polyacrylamide gel. Abortive 
products were visualized by phosphorimagery and quantified using Image J.  
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Supplementary Figure Legends 
 
Fig. S1. Molecular interactions in the Mtb RbpA/σA2 complex 
(A) Stereoview of selected portion of a simulated annealing composite omit electron 
density map (2mFo-DFc), calculated with RbpA omitted, contoured to 1.0 σ.  Map was 
calculated in Phenix (34) with a starting temperature of 5000 K. Clear electron density for 
RbpA is shown. RbpA (purple) and σA2 (orange with the NCR colored cranberry) are shown 
in stick, highlighting the hydrophobic interactions between RbpA residues L94 and L98 
with σANCR-Y258. (B) Schematic highlights polar and ionic interactions between RbpA-SID 
and σA. Interactions between residues are indicated by lines, with ionic interactions colored 
in red, hydrogen bonds colored in gray, and hydrogen bonds mediated by waters colored in 
blue. C. Schematic shows non-polar (van der Waals) interactions between RbpA-SID and σA. 
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Fig. S2.  BTH analysis of Sco RbpA wild-type (WT) and RbpA-V98A/L99A interactions with 
Sco σHrdB. (A) β-galactosidase assays were conducted with E. coli BTH101 strains 
containing:  C1, pUT18 and pKT25; C2, pUT18 and pKT25-hrdB; C3, pUT18-rbpA and 
pKT25; RbpA (WT), pUT18-rbpA(Sco) and pKT25-hrdB; RbpA (V98A/L99A), pUT18-
rbpA(Sco)-V98A/L99A and pKT25-hrdB. rbpA coding sequences were fused to the T18 
subunit of Bordetella pertussis adenylate cyclase in pUT18, whereas the sigma factor genes 
(domains σ2, σ3 and σ4) were fused to the T25 subunit in pKT25 (15).  β-galactosidase 
assays were performed in triplicate (standard deviations indicated) and results are 
presented as % Miller units relative to results obtained with wild-type Sco RbpA). (B) 
Western analysis of total cell extracts of E. coli BTH101 strains containing: RbpA (WT), 
pUT18-rbpA(Sco) and pKT25-hrdB; RbpA (V98A/L99A), pUT18-rbpA(Sco)-V98A/L99A and 
pKT25-hrdB. Extracts were prepared at the time of β-galactosidase assay by precipitation 
with 10% (v/v) trichloroacetic acid, and T18-RbpA fusion proteins were detected using an 
anti-adenylate cyclase toxin antibody (3D1, Santa Cruz Biotechnology). 
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Fig. S3. Formaldehyde cross-linking indicates specificity for promoter DNA interactions 
and a requirement for holoenzyme to form RbpA-DNA cross-links.  
(A) The vapB10 promoter is indicated with the -10 element highlighted in blue. VFJ-28 is 
the fork junction template based on the vapB10 promoter. VFJ-28anti is identical to VFJ-28 
apart from changes at three positions in the -10 element (underlined). (B) Formaldehyde 
cross-linking reactions contained VFL-28 or VFK-28anti, core Mbo RNAP (E, 200 nM), σA 
(400 nM), and native or SUMO-fused derivatives of RbpA (at increasing molar 
concentrations relative to E), as indicated. Cross-linked species were separated by 4-12% 
SDS-PAGE and visualized by phosphorimaging. 
 
 
Fig. S4. Fluorescence anisotropy assays 
(A) The Cy3-labeled vapB10 double-stranded DNA probe (-36 to +1) used for anisotropy 
experiment with the -10 element highlighted in blue. (B) Multi-round abortive initiation 
transcription assays on the vapB10 promoter showing activation by RbpA. Standard error 
bars based on 4 trials.  
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Fig. S5. RbpA R80 and M85 are required for normal growth of S. coelicolor.  
S. coelicolor S129 (∆rbpA), containing the integrative vector pSETΩ, and S129 derivatives 
containing wild-type (rbpA-WT) or mutant derivatives of rbpA  (rbpA-R80A or rbpA-M85A) 
cloned in pSETΩ, were grown on mannitol-soya agar containing spectinomycin 
(25μg/ml). The agar plate was photographed after incubation at 30oC for 3 days.  
 
Fig. S6. Proposed RbpA binding sites on RNAP core are incompatible with current 
structure.  
Protein and DNA elements are colored as in Fig. 2. (A) The proposed RbpA interacting 
residue R381 (red) on RNAP βsubunit was predicted through crosslinking to bind K74 in 
the BL (27). However, RbpA-P77, just 4 residues away from K74, is 53 Å away from βR381 
(direct Cα-Cα distance). (B) The RbpA-RCD binding regions predicted by iron-babe 
cleavage (green) (18) are located at least 80Å away from the beginning of the RCD-SID 
linker (measured as a straight line from the Cα of P77). The clamp region, proposed in this 
study to be the region RbpA would more likely interact with, is highlighted by arrow.  
Table S1. Bacterial strains, plasmids and PCR primers used in this study 
Strain or plasmid Relevant genotype/comments Source/reference 
Strains   
S. coelicolor A3(2)   
S129 J1981 ΔrbpA::aprhyg  (AprHygR) (15) 
E. coli   
ET12567 (pUZ8002) dam, dcm, hsdM. pUZ8002 is a non-transmissible derivative of RK2 
(CmR, KmR) 
(36) 
BL21 (DE3) E. coli B F– ompT hsdS(rB–mB–) dcm gal λ(DE3) endA Hte (TetR) (37) 
BL21 (DE3) pLysS BL21(DE3) pLysS (CmR) (37) 
BTH101 cya-99 (SpcR)  used for bacterial two-hybrid analysis (38) 
Rosetta 2   BL21(DE3) expressing rare codon tRNA genes  Novagen 
   
Plasmids   
   
pBluescript II SK+ E. coli cloning vector; ori pUC18 (AmpR)  
pKT25 Two-hybrid vector; T25 fragment of B. pertussis CyaA for N-terminal 
fusions (KmR) 
(38) 
pUT18 Two-hybrid vector; T18 fragment of B. pertussis CyaA for C-terminal 
fusions (AmpR) 
(38) 
pKT25-hrdB hrdB (codons 211-511) fused to T25 in pKT25 (KmR) (15) 
pKT25-sigA Mtb sigA (codons 1-528)  fused to T25 in pKT25 (KmR) (15) 
pKT25-sigA(RT) sigA (E248R/ K251T, codons 1-528)  fused to T25 in pKT25 (KmR) This study 
pKT25-sigA(VR) sigA (L257V /Y258R , codons 1-528)  fused to T25 in pKT25 (KmR This study 
pKT25-sigA(RTVR) sigA (E248R/K251T/L257V/Y258R, codons 1-528)  fused to T25 in 
pKT25 (KmR 
This study 
pUT18-rbpA(Mtb) Mtb rbpA (codons 1-111) fused to T18 in pUT18 (AmpR) (15) 
pUT18-rbpA(Sco) Mtb rbpA (codons 1-124) fused to T18 in pUT18 (AmpR) (15) 
pSETΩ Integrative cloning vector (SpcR) (15) 
pSX530 pSETΩ containing at the BamHI site a BglII-fragment including rbpA. (15) 
pSX530(R80A) As pSX530 but with rbpA-R80A mutation  This study 
pSX530(M85A) As pSX530 but with rbpA-M85A mutation  This study 
pET15b E. coli expression vector (His6-tagged; AmpR)  Novagen 
pET15b-sigA Mtb sigA cloned in pET15b as a NdeI-BglII fragment This study 
pET15b-sigA(RT) Mtb sigA (E248R/ K251T) cloned in pET15b as a NdeI-BglII fragment This study 
pET15b-sigA(VR) Mtb sigA (L257V /Y258R ) cloned in pET15b as a NdeI-BglII fragment This study 
pET15b-sigA(RTVR) Mtb sigA (E248R/K251T/L257V/Y258R ) cloned in pET15b  as a NdeI-
BglII fragment 
This study 
pET20b E. coli expression vector (native; AmpR) Novagen 
pSX500 pET20b containing M. tuberculosis rbpA cloned as NdeI-BamHI fragment (15) 
pSX500(R79A) pET20b containing M. tuberculosis rbpA-R79A cloned as NdeI-BamHI 
fragment 
This study 
pSX500(M84A) pET20b containing M. tuberculosis rbpA-R79A cloned as NdeI-BamHI 
fragment 
This study 
pET SUMO E. coli expression vector (N-terminal His6/SUMO fusion; KmR) Life Technologies 
pET28 E. coli expression vector (His6-tagged; KmR) Novagen 
pET28-rbpA Mtb rbpA cloned into pET28.   This study 
pET28-rbpA(R79A) As pET28-rbpA but with R79A allele This study 
pSUMO-sigA/rbpA Mtb sigA (codons 224-364) and rbpA (codons 1-111) chemically 
synthesized and cloned as a BamHI-HindIII fragment into a pET SUMO, 
generating a SUMO-sigA fusion 
This study 
pSUMO-rbpA(1-111) pET SUMO containing Mtb rbpA (codons 1-111) fused to C-terminus of 
SUMO as a BamHI-HindIII fragment 
This study 
pSUMO-rbpA(1-71) pET SUMO containing Mtb rbpA (codons 1-71) fused to C-terminus of 
SUMO as a BamHI-HindIII fragment 
This study 
pSUMO-rbpA(72-111) pET SUMO containing Mtb rbpA (codons 72-111) fused to C-terminus of 
SUMO as a BamHI-HindIII fragment 
This study 
   
PCR primers Primer sequence (5’ to 3’) 
(restriction sites indicated in bold) 
 
Plasmid constructs   
pSUMO-RbpA(1-111) GGATCCCATATGGCTGATCGTGTCCTGAGG
AAGCTTTCAGCCG CGCCGACGTGACCGAATG 
 
pSUMO-RbpA(1-71) GGATCCCATATGGCTGATCGTGTCCTGAGG
AAGCTTTCACTCGGGCAGGTCGCCCTCGATCAG 
 
pSUMO-RbpA(72-111) GGATCCCATATGGAGCCGAAGAAGGTTAAGCCG  
 
AAGCTTTCAGCCG CGCCGACGTGACCGAATG 
Table S3: Average KDs of RNAP binding to Cy3 labeled ssDNA (-12 to +1) with 
and without RbpA  
 
Promoter Sequence No RbpA KD (μM) RbpA KD (μM) 
Consensus *TATAATGGGAAGG 0.38 ± 0.07 
 
0.33 ± 0.04 
 
AP3 *TAGACTGGCAGGG 2.24 ± 0.41 
 
1.88 ± 0.31 
 
vapB *TATGATATGGTGT 1.62 ± 0.26 
 
1.77 ± 0.15 
 
Average KDs of RNAP binding to Cy3 labeled ssDNA (-12 to +1) were 
determined using fluorescence anisotropy. The addition of RbpA to the assay 
has no significant effect on RNAP binding to ssDNA composed of the -10 and 
discriminator elements.  
-10 element is highlighted in blue. Error is based off of triplicate trials. 
 






